SBRT 2016

First page Previous page 782 Next page Last page

Safety & efficacy in elderly patients

OS

Takeda 2013

54 % @ 3a

Sandhu 2013

74 % @ 2a

Haasebeek 2010

45 % @ 3a

• Promising OS considering very advanced age and malignant disease

40

/ M Guckenberger - SBRT stage I NSCLC - HICARE 2015

Made with